Quality indicators of laryngeal cancer care in the elderly

Laryngoscope

Volumn 124, Issue 9, 2014, Pages 2049-2056

  Gourin, Christine G ^a   Frick, Kevin D ^c,d   Blackford, Amanda L ^a   Herbert, Robert J ^d   Quon, Harry ^b   Forastiere, Arlene A ^a   Eisele, David W ^a   Dy, Sydney M ^a,d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

chemotherapy; costs; elderly; Laryngeal neoplasms; quality; radiation; SEER Medicare; squamous cell cancer; surgery; survival; treatment

Indexed keywords

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CORRELATIONAL STUDY; DISEASE SEVERITY; DISTANT METASTASIS; FOLLOW UP; GERIATRIC PATIENT; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPICE CARE; HUMAN; LARYNGEAL SQUAMOUS CELL CANCER; LARYNX CANCER; MAJOR CLINICAL STUDY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERMINAL CARE;

CHEMOTHERAPY; COSTS; ELDERLY; LARYNGEAL NEOPLASMS; QUALITY; RADIATION; SEER-MEDICARE; SQUAMOUS CELL CANCER; SURGERY; SURVIVAL; TREATMENT;

AGED; AGED, 80 AND OVER; COSTS AND COST ANALYSIS; CROSS-SECTIONAL STUDIES; HUMANS; LARYNGEAL NEOPLASMS; NEOPLASMS, SQUAMOUS CELL; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE;

EID: 84906939477     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24593     Document Type: Article

References (23)

1. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press, 2001.
2. National Cancer Policy Board, Institute of Medicine and National Research Council. Ensuring quality cancer care. Hewitt M, Simone JV (eds). Washington, DC: National Academy Press, 1999.
3. Institute of Medicine. Delivering high-quality cancer care. Levit LA, Balogh EP, Nass SJ, Ganz PA (eds). Washington, DC: National Academy Press, 2013.
4. Crossing the quality chasm: the IOM Health Care Quality Initiative. http://www.iom.edu/Global/News%20Announcements/Crossing-the-Quality-Chasm-The- IOM-Health-Care-Quality-Initiative.aspx. Accessed June 9, 2013.
5. Seow H, Snyder CF, Mularski RA, et al. A framework for assessing quality indicators for cancer care at the end of life. J Pain Symptom Manage 2009; 38: 903-912.
6. Dy SM, Lorenz KA, ONeill SM, et al. Cancer Quality-ASSIST supportive oncology quality indicator set. Cancer 2010; 116: 3267-3275.
7. Gourin CG, Dy SM, Herbert RJ, et al. Treatment, survival and costs of laryngeal cancer care in the elderly. Laryngoscope. Epub ahead of print.
8. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Eng J Med, 1991; 324: 1685-1690.
9. Forastiere A, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Eng J Med 2003; 349: 2091-2098.
10. Charlson ME, Pompei P, Ales KL, Mackenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Disease 1987; 40: 373-383.
11. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
12. Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000; 53: 1258-1267.
13. National Comprehensive Cancer Network. NCCN Guidelines for head and neck cancer care. http://www.nccn.org/professionals/physician-gls/pdf/head-and-neck. pdf. Accessed June 9, 2013.
14. Earle CC, Park ER, Lai B, et al. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 2003; 21: 1133-1138.
15. Earle CC, Neville BA, Landrum MB, et al. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004; 22: 315-321.
16. Earle CC, Neville BA, Landrum MB, et al. Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care 2005; 17: 505-509.
17. Mack JW, Cronin A, Keating NL, et al. Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol 2012; 30: 4387-4395.
18. Weber RS, Lewis CM,., Eastman SD, et al. Quality and performance indicators in an academic department of head and neck surgery. Arch Otolaryngol Head Neck Surg 2010; 136: 1212-1218.
19. Shellenberger TD, Madero-Vishal R, Weber RS,. Quality indicators in head and neck operations. A comparison with published benchmarks. Arch Otolaryngol Head Neck Surg 2011; 137: 1086-1093.
20. Snyder CF, Frick KD, Blackford AL, et al. How does initial treatment choice affect short and long-term costs for clinically localized prostate cancer? Cancer 2010; 116: 5391-5399.
21. Gourin CG, Forastiere AA, Marur S, Sanguineti G, Koch WM, Bristow RE,. Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care. Laryngoscope 2011; 121: 85-90.
22. Gourin CG, Frick KD,. National trends in laryngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care. Laryngoscope 2012; 122: 88-94.
23. Birkmeyer JD, Sun Y, Wong SL, Stukel TA,. Hospital volume and late survival after cancer surgery. Ann Surg 2007; 245: 777-783.